Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Next Generation Diabetes Therapy and Drug Delivery market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Next Generation Diabetes Therapy and Drug Deliverymarket, defines the market attractiveness level of Next Generation Diabetes Therapy and Drug Delivery market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Next Generation Diabetes Therapy and Drug Delivery industry, describes the types of Next Generation Diabetes Therapy and Drug Delivery market, the applications of major players and the market size, and deeply analyzes the current situation of the global Next Generation Diabetes Therapy and Drug Delivery market and the development prospects and opportunities of Next Generation Diabetes Therapy and Drug Delivery industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Next Generation Diabetes Therapy and Drug Delivery market in Chapter 13.
By Player:
Eli Lilly and Company
Novo Nordisk
Sanofi
Transdermal Specialties
Medtronic
Senseonics
Zosano Pharma
Medtech
Relmada Therapeutics
Johnson & Johnson
Synertech
MannKind Corporation
Dexcom
Abbott Laboratories
Enteris BioPharma
By Type:
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
By End-User:
Diagnostic/Clinics
ICUs
Home Healthcare
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Next Generation Diabetes Therapy and Drug Delivery Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Next Generation Diabetes Therapy and Drug Delivery Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Next Generation Diabetes Therapy and Drug Delivery Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Next Generation Diabetes Therapy and Drug Delivery Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Next Generation Diabetes Therapy and Drug Delivery Market Analysis and Outlook to 2022
-
7.1 Global Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
7.2 United States Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
7.3 Europe Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
7.4 China Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
7.5 Japan Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
7.6 India Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
-
7.7 South Korea Next Generation Diabetes Therapy and Drug Delivery Consumption (2017-2022)
8 Region and Country-wise Next Generation Diabetes Therapy and Drug Delivery Market Analysis and Outlook to 2028
-
8.1 Global Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
8.2 United States Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
8.3 Europe Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
8.4 China Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
8.5 Japan Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
8.6 India Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
-
8.7 South Korea Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast (2022-2028)
9 Global Next Generation Diabetes Therapy and Drug Delivery Market Outlook by Types and Applications to 2022
-
9.1 Global Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Inhalable Insulin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Oral Insulin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Insulin Patches Consumption and Growth Rate (2017-2022)
-
9.1.4 Global CGM Systems Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Artificial Pancreas Consumption and Growth Rate (2017-2022)
-
9.2 Global Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Diagnostic/Clinics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global ICUs Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Home Healthcare Consumption and Growth Rate (2017-2022)
10 Global Next Generation Diabetes Therapy and Drug Delivery Market Outlook by Types and Applications to 2028
-
10.1 Global Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Inhalable Insulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Oral Insulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Insulin Patches Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global CGM Systems Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Artificial Pancreas Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Diagnostic/Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global ICUs Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Home Healthcare Consumption Forecast and Growth Rate (2022-2028)
11 Global Next Generation Diabetes Therapy and Drug Delivery Import and Export Analysis (Top 5 Countries)
-
11.1 Global Next Generation Diabetes Therapy and Drug Delivery Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Next Generation Diabetes Therapy and Drug Delivery Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Next Generation Diabetes Therapy and Drug Delivery Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Next Generation Diabetes Therapy and Drug Delivery Market Competitive Analysis
-
14.1 Eli Lilly and Company
-
14.1.1 Eli Lilly and Company Company Details
-
14.1.2 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
14.2 Novo Nordisk
-
14.2.1 Novo Nordisk Company Details
-
14.2.2 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
14.3 Sanofi
-
14.3.1 Sanofi Company Details
-
14.3.2 Sanofi Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
14.4 Transdermal Specialties
-
14.4.1 Transdermal Specialties Company Details
-
14.4.2 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
14.5 Medtronic
-
14.5.1 Medtronic Company Details
-
14.5.2 Medtronic Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
14.6 Senseonics
-
14.6.1 Senseonics Company Details
-
14.6.2 Senseonics Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
14.7 Zosano Pharma
-
14.7.1 Zosano Pharma Company Details
-
14.7.2 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
14.8 Medtech
-
14.8.1 Medtech Company Details
-
14.8.2 Medtech Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
14.9 Relmada Therapeutics
-
14.9.1 Relmada Therapeutics Company Details
-
14.9.2 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
14.10 Johnson & Johnson
-
14.10.1 Johnson & Johnson Company Details
-
14.10.2 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
14.11 Synertech
-
14.11.1 Synertech Company Details
-
14.11.2 Synertech Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
14.12 MannKind Corporation
-
14.12.1 MannKind Corporation Company Details
-
14.12.2 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
14.13 Dexcom
-
14.13.1 Dexcom Company Details
-
14.13.2 Dexcom Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
14.14 Abbott Laboratories
-
14.14.1 Abbott Laboratories Company Details
-
14.14.2 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
14.15 Enteris BioPharma
-
14.15.1 Enteris BioPharma Company Details
-
14.15.2 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Next Generation Diabetes Therapy and Drug Delivery
-
Figure Next Generation Diabetes Therapy and Drug Delivery Picture
-
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Next Generation Diabetes Therapy and Drug Delivery Consumption by Country (2017-2022)
-
Figure United States Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table Europe Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure China Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Japan Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure India Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure South Korea Next Generation Diabetes Therapy and Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Global Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure United States Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Next Generation Diabetes Therapy and Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inhalable Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Patches Consumption and Growth Rate (2017-2022)
-
Figure Global CGM Systems Consumption and Growth Rate (2017-2022)
-
Figure Global Artificial Pancreas Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic/Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global ICUs Consumption and Growth Rate (2017-2022)
-
Figure Global Home Healthcare Consumption and Growth Rate (2017-2022)
-
Figure Global Inhalable Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Patches Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CGM Systems Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Artificial Pancreas Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic/Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ICUs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Healthcare Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Next Generation Diabetes Therapy and Drug Delivery Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Next Generation Diabetes Therapy and Drug Delivery Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
Table Transdermal Specialties (Foundation Year, Company Profile and etc.)
-
Table Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
Table Medtronic (Foundation Year, Company Profile and etc.)
-
Table Medtronic Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medtronic Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
Table Senseonics (Foundation Year, Company Profile and etc.)
-
Table Senseonics Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Senseonics Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
Table Zosano Pharma (Foundation Year, Company Profile and etc.)
-
Table Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
Table Medtech (Foundation Year, Company Profile and etc.)
-
Table Medtech Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medtech Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
Table Relmada Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
Table Synertech (Foundation Year, Company Profile and etc.)
-
Table Synertech Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Synertech Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
Table MannKind Corporation (Foundation Year, Company Profile and etc.)
-
Table MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
Table Dexcom (Foundation Year, Company Profile and etc.)
-
Table Dexcom Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dexcom Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
Table Enteris BioPharma (Foundation Year, Company Profile and etc.)
-
Table Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product and Service
-
